CRYPTOCURRENCY
AI-Powered Robotic Surgery: Breakthroughs in Autonomous Operations
Researchers from Johns Hopkins and Stanford have advanced robotic surgery by integrating AI, enabling robots to autonomously perform complex surgical tasks with precision.
AI Innovation: Retinal Scans Offer Early Alzheimer's Detection
AI technology, Eye-AD, analyzes retinal scans to detect early signs of Alzheimer's, providing a non-invasive and rapid screening method, according to NVIDIA's study.
Mitsui & Co's Xeureka Utilizes NVIDIA AI for Secure Drug Discovery
Xeureka, a subsidiary of Mitsui & Co, leverages NVIDIA's AI platform to safely share healthcare data, enhancing drug discovery efforts through advanced confidential computing.
Japan Advances AI in Healthcare: Innovations in Drug Design and Robotics
Japan is leveraging AI to revolutionize healthcare with advancements in drug discovery, robotics, and digital health platforms, showcased at the NVIDIA AI Summit Japan.
AI Model Revolutionizes Breast Cancer Metastasis Detection Without Surgery
A groundbreaking AI model developed by UT Southwestern Medical Center researchers can detect breast cancer metastasis without surgery, using advanced MRI analysis.
NVIDIA's Nemotron-4 Hindi Model Transforms India's Healthcare AI Landscape
NVIDIA introduces the Nemotron-4 Hindi NIM microservice, enhancing AI applications in India's healthcare sector, impacting life sciences, medical imaging, and drug discovery.
AI Model SLIViT Revolutionizes 3D Medical Image Analysis
UCLA researchers unveil SLIViT, an AI model that swiftly analyzes 3D medical images, outperforming traditional methods and democratizing medical imaging with cost-effective solutions.
AI Integration in U.S. Healthcare: NVIDIA's Role in Revolutionizing Medical Research
NVIDIA's AI tools, including NIM microservices, are transforming the U.S. healthcare landscape, enhancing research and clinical practices with cutting-edge AI technology.
AI Model TxGNN Utilizes Zero-Shot Learning to Repurpose Drugs for Rare Diseases
Harvard scientists develop TxGNN, an AI model using zero-shot learning to identify new uses for existing drugs, potentially closing treatment gaps for rare diseases.
SFC Initiates Legal Action Against SoftMedx Healthcare and Former Directors
The SFC has commenced legal proceedings against SoftMedx Healthcare Limited and its former directors for alleged regulatory violations.